Revised List of Pharma Patents - Controller General of Patents ...

More documents

Recommendations

Info

454 195/MUMNP/2005 209147 21/08/2007455 IN/PCT/2002/1718/MUM 209150 22/08/2007456 560/MUMNP/2003 209158 22/08/2007457 999/MUMNP/2003 209165 22/08/2007458 514/MUM/2003 209166 22/08/2007459 IN/PCT/2001/558/MUM 209167 22/08/2007460 IN/PCT/2002/1274/MUM 209181 22/08/2007461 IN/PCT/2002/714/CHE 209183 22-08-2007462 100/CHENP/2003 209184 22-08-2007463 109/CHENP/2003 209185 22-08-2007464 220/CHENP/2003 209194 22-08-2007465 226/CHENP/2003 209195 22-08-2007466 246/CHENP/2003 209200 22-08-2007467 492/CHENP/2003 209213 22-08-2007468 631/CHENP/2003 209222 22-08-2007469 80/CAL/1995 209226 23-08-2007470 195/CAL/1995 209227 23-08-2007TRANS 4-(3,4-DICHLOROPHENYL)-1,2,3,4-TETRAHYDRO-1-NAPTHALENAMINE AND ITS SEPRACOR INCFORMAMIDECOMPOUND AND COMPOSITIO OF THE SAIDASTRAZENECA ABCOMPOUND.COMPOUND BENZOTHIAZEPINE OF FORMULA(I)AND PROCESS FOR PREPARATIONASTRAZENECA ABTHEREOF….CRYSTALLINE AZITHROMYCINPFIZER PRODUCT INCSESQUITHYDRATELIQUID PHARMACEUTICAL FORMULATIONCOMPRISING PRADOFLOXACIN BOUND TO AN BAYER AKTIENGESELLSCHAFTION EXCHANGERA CONTROLLED RELEASE FORMULATIONCONTAINING GALANTAMINE AS THE ACTIVE JANSSEN PHARMACEUTICA N.V.INGREDIENTPHARMACEUTICAL COMPOSITION FOR THE BOEHRINGER INGELHEIM PHARMACEUTICALTREATMENT OF MYOCARDIAL DISEASE INCSPIRO(2H-1-BENZOPYRAN-2,4'-PIPERIDINE)DERIVATES AS GLYCINE TRANSPORT N.V. ORGANONINHIBITORS4-PHENYL-PYRIDINE DERIVATIVES ASF. HOFFMANN LA ROCHE AGNEUROKININ-1 RECEPTOR ANTAGONISTSA PHARMACEUTICAL COMPOSITIONCOMPRISING 5-HT2c RECEPTOR AGONIST AND BIOVITRUM AB5-HT6 RECEPTOR ANTOGONISTA VACCINATION AGAINST HOST CELL- M/S. LOHMANN ANIMAL HEALTH GMBH & COASSOCIATED HERPESVIRUSESKGINDOLE DERIVATIVES FOR THE TREATMENTM/S. H. LUNDBECK A/SOF CNS DISORDERSNEW MACROLIDES ANTIBIOTICS OF FORMULAM/S. BASILEA PHARMACEUTICA AGI WITH ANTIBACTERIAL ACTIVITYPYRAZOLE DERIVATIVES FOR THEM/S. F. HOFFMANN-LA ROCHE AGTREATMENT OF VIRAL DISEASESA PHARMACEUTICAL COMPOSITION FORM/S. SOLVAY PHARMACEUTICALS B.VPROLONGED RELEASE OF ACTIVE"STABILISED PHARMACEUTICALCOMPOSITION COMPRISING BUPROPIONTHE WELLCOME FOUNDATION LIMITEDHYDROCHLORIDE AND METHOD FORSTABILISING BUPROPION HYDROCHLORIDE"IONTOPHORETIC DELIVERY OF ANJANSSEN PHARMACEUTICA N.V.ANTIMIGRAINE DRUG
471 218/CAL/2001 209228 23-08-2007"A POLYNUCLEOTIDE THAT IS SUITABLE FORACCELERATING A BIOSYNTHESIS OF ML236BAND THE METHOD FOR PRODUCING ML236BSANKYO COMPANY, LIMITEDBY USING THE POLYNUCLEOTIDE"472 652/CAL/1998 209241 23-08-2007 FLUOXETINE ENTERIC PELLETS ELI LILLY AND COMPANYPHARMACEUTICAL COMBINATIONSCOMPRISING NONSEDATING473 1641/CAL/1998 209250 23-08-2007ANTIHISTAMINES AND A-ADRENERGIG DRUGASTA MEDICAL AKTIENGESELISCHAFTFOR THE TOPICAL TREATMENT OFRHINITIS/CONJNUCTIVITIS AND COLD, COLD-LIKE AND/OR FLU SYMPTOMS474 IN/PCT/2002/00785/DEL 209251 23-08-2007PYRROLE SUBSTITUTED 2-INDOLINONEPROTEIN KINASE INHIBITORSSUGEN INC., USA475 2000/CAL/1996 209253 23-08-2007 PROTEIN KINASE C INHIBITOR ELI LILLY AND COMPANY476 2225/CAL/1996 209255 23-08-2007"4-(BENZIMIDAZOLY-ANDIMIDAZOPYRIDINYL) PIPERIDINEDERIVATIVES AS SUBSTANCE PANTAGONISTJANSSEN PHARMACEUTICA N.V.477 327/MUM/2003 209289 23/08/2007 MICRO EMULSION IMMUNOSUPPRESENTS CIPLA LIMITED478 IN/PCT/2001/1152/MUM 209290 23/08/2007CILOSTAZOL PREPARATION479 IN/PCT/2002/1256/MUM 209291 23/08/2007480 127/MUMNP/2004 209309 24/08/2007481 IN/PCT/2002/344/MUM 209328 24/08/2007482 67/MUM/2003 209337 24/08/2007COMPOSITIONS CONTAININGPOLYCARBONATEA MONOLITHIC SUSTAINED RELEASECOMPOSITION OF METFORMINHYDROCHLORIDEQUINAZOLINE DERIVATIVES AS VEGFINHIBITORSDIFLUOROETHYLTHIAZOLYLCARBOXANILIDES OF THE FORMULA ( I ) AND THECOMPOSITION COMPRISING THEMOTSUKA PHARMACEUTIC AL COMPANYLIMITEDBAYER AKTIENGESELLSCHAFTUSV LIMITEDASTRAZENECA ABBAYER CROPSCIENCES GMBHA NEUROTROPHIC COMPOSITION COMPRISING483 1167/CHENP/2003 209347 27-08-2007M/S. ASTELLAS PHARMA INCA COMPOUND OF FORMULA IIMIDAZO PYRIMIDINE DERIVATIVES AS484 1473/CHENP/2003 209367 27-08-2007MERCK SHARP & DOHME LIMITEDLIGANDS FOR GABA RECEPTORSPYRIDO(2,1-A)ISOQUINOLINE DERIVATIVES AS485 1416/CHENP/2004 209390 28-08-2007F. HOFFMANN-LA ROCHE AGDPP-IV INHIBITORSA COMPOUND OR A TARGETABLE486 2815/CHENP/2004 209394 28-08-2007IMMUNOMEDICS, INCCONSTRUCT FOR THERAPEUTIC USE" ANA ORALLY ADMINISTRABLE TABLET" PENWEST PHARMACEUTICALS487 327/KOLNP/2003 209411 30-08-2007COMPANY488 752/KOLNP/2004 209420 30-08-2007 "A SULPHONAMIDE DERIVATIVE" LABORATORIOS DEL DR. ESTEVE, S.A.489 2167/CAL/1998 209431 30-08-2007 "IBUPROFEN COMPOSITION" MCNEIL-PPC,INC490 IN/PCT/2002/561/KOL 209442 30-08-2007SMALL PEPTIDES FOR TREATMENT OFERECTILE DYSFUNCTIONZENTARIS AG
Page 1: Product Patents in Pharmaceuticals
Page 4 and 5: 65 IN/PCT/2001/1516/CHE 202356 09-1
Page 6 and 7: 99 IN/PCT/2000/664/MUM 203095 27/10
Page 8 and 9: 136 810/BOM/1999 204043 27/02/2007
Page 10 and 11: 173 IN/PCT/2001/503/MUM 204672 01-0
Page 12 and 13: 219 1079/CHENP/2004 205676 09-04-20
Page 14 and 15: 258 IN/PCT/2002/1868/MUM 206233 19/
Page 16 and 17: 303 2609/MAS/1998 206960 16-05-2007
Page 18 and 19: 340 333/MUMNP/2005 207881 29/06/200
Page 20 and 21: 380 782/MUM/2004 208592 02-08-2007A
Page 22 and 23: 417 IN/PCT/2002/1605/CHE 208917 16-
Page 26 and 27: 491 574/DEL/2001 209451 30-08-2007H
Page 28 and 29: 538 194/DEL/2004 209857 07-09-2007A
Page 30 and 31: 577 3207/DEL/2005 210329 28-09-2007
Page 32 and 33: A PHARMACEUTICAL PRODUCT FORCOUNTER
Page 34 and 35: 653 382/MUMNP/2005 211375 26/10/200
Page 36 and 37: 688 452/CHENP/2003 211580 05-11-200
Page 38 and 39: 730 99/CHENP/2004 211840 13-11-2007
Page 40 and 41: 767 1151/CHENP/2003 212206 26-11-20
Page 42 and 43: 800 IN/PCT/2001/33/KOL 212615 04-12
Page 44 and 45: 842 1329/CHENP/2003 213069 19-12-20
Page 46 and 47: 881 119/MUMNP/2005 213311 27-12-200
Page 48 and 49: 922 IN/PCT/2002/1444/MUM 213842 21/
Page 50 and 51: 961 614/MUMNP/2003 214197 07-02-200
Page 52 and 53: HERBAL COMPOSITION FOR THE TREATMEN
Page 54 and 55: 1031 1535/KOLNP/2004 215531 27-02-2
Page 56 and 57: 1073 37/DEL/2000 216398 12-03-2008L
Page 58 and 59: 1110 IN/PCT/2000/668/KOL 216904 19-
Page 60 and 61: 1148 2521/DELNP/2004 217950 31-03-2
Page 62 and 63: 1186 119/MUM/2004 218479 02-04-2008
Page 64 and 65: 1228 IN/PCT/2001/01235/MUM 218742 1
Page 66 and 67: 1264 811/MUM/2004 219014 16/04/2008
Page 68: 1306 721/MAS/1996 219271 28-04-2008
Page 71 and 72: RECOMBINANT NUCLEIC ACID MOLECULES1
Page 73 and 74: 1401 2945/DELNP/2005 220218 19-05-2
Page 75 and 76:
1440 713/DEL/2002 220683 02-06-2008
Page 77 and 78:
1481 305/DEL/2002 221053 13-06-2008
Page 79 and 80:
1521 IN/PCT/2002/162/CHE 221395 23-
Page 81 and 82:
AN AYURVEDIC COMPOSITION FOR ORAL15
Page 83 and 84:
1,2,3-TRISUBSTITUTED ARYL ANDHETERO
Page 85 and 86:
1631 IN/PCT/2002/345/CHE 222560 14-
Page 87 and 88:
1670 773/MUMNP/2003 222823 25/08/20
Page 89 and 90:
1709 IN/PCT/2002/00850/DEL 223094 0
Page 91 and 92:
1743 1811/CHENP/2004 223246 09-09-2
Page 93 and 94:
1779 IN/PCT/2001/1002/CHE 223544 12
Page 95 and 96:
1814 2844/DEL/1996 223754 23-09-200
Page 97 and 98:
1852 00822/DELNP/2003 224186 01-10-
Page 99 and 100:
1890 2694/DELNP/2004 224371 13-10-2
Page 101 and 102:
1927 2684/DEL/1997 224571 17-10-200
Page 103 and 104:
1961 3275/DELNP/2005 224809 22-10-2
Page 105 and 106:
1997 3330/DELNP/2004 225015 29-10-2
Page 107 and 108:
2032 IN/PCT/2001/9/KOL 225227 05-11
Page 109 and 110:
2068 434/KOLNP/2005 225441 12-11-20
Page 111 and 112:
1,2,4-OXADIAZOLE DERIVATIVES AS HPP
Page 113 and 114:
2147 668/MUM/2002 225930 03-12-2008
Page 115 and 116:
2186 967/MAS/1997 226322 17-12-2008
Page 117 and 118:
2220 1029/KOLNP/2004 226708 24-12-2
Page 119 and 120:
2253 351/CHENP/2004 227043 31-12-20
Page 121 and 122:
2293 1355/MAS/1996 227418 07-01-200
Page 123 and 124:
FARNESYL DIBENZODIAZEPINONES,2328 1
Page 125 and 126:
2367 910/CHENP/2004 227963 27-01-20
Page 127 and 128:
2406 2262/CHENP/2005 228171 28-01-2
Page 129 and 130:
2449 1660/KOLNP/2005 228778 10-02-2
Page 131 and 132:
2490 1538/CHENP/2004 229051 13-02-2
Page 133 and 134:
2527 842/CHENP/2004 229276 16-02-20
Page 135 and 136:
2-ALKYNYL-AND-2-ALKENYL-PYRAZOLO-[4
Page 137 and 138:
2605 1557/CHENP/2003 229915 24-02-2
Page 139 and 140:
2641 664/MUM/2001 230188 25/2/2009B
Page 141 and 142:
2684 650/CHENP/2004 230522 27-02-20
Page 143 and 144:
2723 2376/CHENP/2005 231260 04-03-2
Page 145 and 146:
2760 3714/DELNP/2005 231497 05-03-2
Page 147 and 148:
2797 2043/CHENP/2005 232652 20-03-2
Page 149 and 150:
2833 800/CHENP/2005 233747 02-04-20
Page 151 and 152:
A RECOMBINANT NUCLEIC ACID MOLECULE
Page 153 and 154:
NOVEL 4, 10ß-DIACETOXY-2A-BENZOYLO
Page 155 and 156:
2950 1015/MUMNP/2006 234427 28/5/20
Page 157 and 158:
2984 5989/DELNP/2005 234665 10-06-2
Page 159 and 160:
3022 1586/DEL/2004 235036 24-06-200
Page 161 and 162:
3059 5604/DELNP/2006 235498 06-07-2
Page 163 and 164:
3098 262/KOL/2006 235813 02-09-2009
Page 165 and 166:
3133 720/DELNP/2005 236122 29-09-20
Page 167 and 168:
3165 70/KOLNP/2005 236431 29-10-200
Page 169 and 170:
3197 391/DELNP/2003 236723 17-11-20
Page 171 and 172:
3233 21/CHENP/2006 237090 04-12-200
Page 173 and 174:
3275 4817/CHENP/2006 237397 18-12-2
Page 175 and 176:
3310 1389/MUMNP/2005 237747 18/12/2
Page 177 and 178:
3346 3616/CHENP/2006 238025 18-01-2
Page 179 and 180:
3385 01436/DELNP/2003 238542 10-02-
Page 181 and 182:
3418 787/KOLNP/2004 238836 24-02-20
Page 183 and 184:
3452 4627/DELNP/2005 239487 23-03-2
Page 185:
* N.B.- Twenty- year term of patent
show all

Revised List of Pharma Patents - Controller General of Patents ...

Create successful ePaper yourself

Delete template?

Save as template?